Table 3. Predictors of lost to follow up among HIV positive children on ART, Ethiopia, 2023.
Predictors | Included studies | HR (95% CI) | Pooled HR (95% CI) | Heterogeneity | |
---|---|---|---|---|---|
Advanced HIV disease | Menshw et al (2021) | 2.2 0 (1.40; 3.34) | 2.20 (1.71,2.73) | I2 = 0%, p-value = 0.94 | |
Fisiha et al (2020) | 2.00 (1.10; 3.10) | ||||
Melaku et al (2017) | 2.20 (1.6; 3.10) | ||||
Poor or fair ART treatment adherence | Menshw et al (2021) | 6.6 0 (4.11; 10.56) | 2.92 (1.31; 6.54) | I2 = 90.8%, p-value < 0.001 | |
Fisiha et al (2020) | 1.70 (1.10; 2.11) | ||||
Hibstie et al (2020) | 2.30 (1.40; 3.70) | ||||
Having Opportunistic infection | Fetene et al(2018) | 2.26(1.08; 4.71) | 2.59 (1.39; 4.78) | I2 = 0%, p-value = 0.51 | |
Bankere et al (2022) | 3.54 (1.152; 10.87) | ||||
Age between 1–5 years | Menshw et al (2021) | 1.60 (1.05; 2.46) | 2.10 (1.44; 2.95) | I2 = 57.5%, p-value = 0.095 | |
Fetene et al(2018) | 3.86 (1.73; 8.61) | ||||
Biru et al (2018) | 3.76 (1.16; 12.27) | ||||
Rural residence | Hibstie et al (2020) | 3.20 (2.00; 5.50) | 1.15 (0.15; 8.84) | I2 = 95%. p-value < 0.001 | |
Melaku et al (2017) | 0.40 (0.20; 0.90) | ||||
Biru et al (2018) | 3.57 (11.64; 11.64) |